WallStreetZenWallStreetZen

NASDAQ: ABUS
Arbutus Biopharma Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Arbutus Biopharma earnings were $160.7M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ABUS earnings report on Mar 31, 2026 announced Q1 2026 earnings of $169.7M, down 4,618% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ABUS reported annual earnings of -$33.5M, with -52.1% growth.

ABUS earnings history

Current Revenue
$191.4M
Current Earnings
$160.7M
Current Profit Margin
84%

ABUS Return on Equity

Current Company
129.3%
Current Industry
-146.3%
Current Market
5.1%
ABUS's Return on Equity (129.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ABUS Return on Assets

Current Company
112.2%
Current Industry
-11.8%
ABUS is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ABUS announces earnings.

ABUS Return on Capital Employed

Current Company
59.11%
Current Industry
-7.8%
ABUS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABUS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABUS$160.85M$160.72MN/A$0.84
DRTS-$41.49M-$42.63MN/A-$0.53
TBPH$144.43M$114.54M-93.17%$2.27
KURA-$291.88M-$294.57MN/A-$3.35
VOR-$876.54M-$883.08MN/A-$70.13
View Top Biotech Stocks

Arbutus Biopharma Earnings Reports & History FAQ

What were Arbutus Biopharma's earnings last quarter?

Arbutus Biopharma (NASDAQ: ABUS) reported Q1 2026 earnings per share (EPS) of $0.88, up 776.92% year over year. Total ABUS earnings for the quarter were $169.70 million. In the same quarter last year, Arbutus Biopharma's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Arbutus Biopharma stock.

Is Arbutus Biopharma profitable or losing money?

As of the last Arbutus Biopharma earnings report, Arbutus Biopharma is currently profitable. Arbutus Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $160.72 million, a 309.9% decrease year over year.

What was ABUS's earnings growth in the past year?

As of Arbutus Biopharma's earnings date in Q2 2026, Arbutus Biopharma's earnings has grown year over year. ABUS earnings in the past year totalled $160.72 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.